Allergy Therapeutics
AGY.L
#6604
Rank
A$1.06 B
Marketcap
A$0.17
Share price
0.00%
Change (1 day)
8.60%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2025: -A$74.91 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are A$75.57 Million. In 2025 the company made an earning of -A$74.91 Million a decrease over its 2024 earnings that were of -A$68.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025-A$74.91 Million8.65%
2024-A$68.94 Million-6.69%
2023-A$73.89 Million244.94%
2022-A$21.42 Million-404.35%
2021A$7.03 M-49.42%
2020A$13.91 M83.48%
2019A$7.58 M-159.83%
2018-A$12.68 Million255.48%
2017-A$3.57 Million-84.06%
2016-A$22.38 Million-1667.33%
2015A$1.42 M-44.68%
2014A$2.58 M130.59%
2013A$1.11 M-19.89%
2012A$1.39 M-127.05%
2011-A$5.17 Million2009.96%
2010-A$0.25 Million-99.07%
2009-A$26.23 Million-53.23%
2008-A$56.08 Million-21.86%
2007-A$71.77 Million356.94%
2006-A$15.71 Million230.75%
2005-A$4.75 Million-217.9%
2004A$4.02 M-58.79%
2003A$9.77 M-196.03%
2002-A$10.18 Million